Santoro, MM;
Sabin, C;
Forbici, F;
Bansi, L;
Dunn, D;
Fearnhill, E;
Boumis, E;
... Mussini, C; + view all
(2013)
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
HIV Med
, 14
(9)
571 - 577.
10.1111/hiv.12044.
Preview |
PDF
hiv12044.pdf Download (174kB) |
Abstract
We evaluated the emergence of drug resistance in patients failing first-line regimens containing one nonnucleoside reverse transcriptase inhibitor (NNRTI) administered with zidovudine (ZDV) + lamivudine (the ZDV group) or non-thymidine analogues (non-TAs) (tenofovir or abacavir, + lamivudine or emtricitabine; the non-TA group).
Archive Staff Only
View Item |